Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Acer Therapeutics Inc.
Newton or Cambridge*, Massachusetts, United Statesacertx.com ↗
- Ownership
- Public · ACER
- Employees
- ~33
- Development stage
- Other
01
Overview
Acer Therapeutics has achieved FDA approval and commercial launch of OLPRUVA™ for certain UCDs. Its pivotal Phase 3 trial of EDSIVO™ in COL3A1-positive vEDS patients remains ongoing. Development of ACER-801 was paused after a Phase 2a trial in VMS and other indications. The company focuses on rare diseases with significant unmet needs.
- Therapeutic areas
- PsychiatryMetabolic DisordersWomen's HealthOncologyRare Diseases
- Modalities
- small molecules (notably sodium phenylbutyrate, celiprolol, osanetant)
- Industry
- Biotech
02
Partnerships
Previously had agreements with Relief Therapeutics regarding OLPRUVA™Sanofi regarding osanetant rights acquisitionEmory University regarding IP on neurokinin antagonists.As of recent updates, regained worldwide rights to OLPRUVA™, excluding Europe.
03
Financials
- Market cap
- $2.7B
- Total revenue
- $8.4B
- Enterprise value
- $3B
Beyond the preview
Go deeper on Acer Therapeutics Inc..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Acer Therapeutics Inc..